IAIM
NRIX icon

International Assets Investment Management’s Nurix Therapeutics NRIX Stock Holding History

International Assets Investment Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$4.49K – 1491
2024
Q3 		$4.49K Sell
200
-175
-47% -$3.96K ﹤0.01% 1656
2024
Q2 		$7.83K Buy
+375
New +$5.84K ﹤0.01% 1738

Other funds holding NRIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

International Assets Investment Management's NRIX Position: Q4 2024 in Review

International Assets Investment Management sold out of Nurix Therapeutics (NRIX) in Q4 2024, closing a stake of 200 shares — an estimated $4.49K sold.

International Assets Investment Management first reported a position in NRIX in Q2 2024 and held it in 2 quarters. The position peaked at $7.83K in Q2 2024. 175 funds tracked by Wall St. Rank hold NRIX as of Q4 2024.

  • International Assets Investment Management reported no remaining Nurix Therapeutics position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 200 Nurix Therapeutics shares in Q4 2024, an estimated $4.49K.
  • International Assets Investment Management first reported a position in Nurix Therapeutics in Q2 2024 and held it in 2 quarters.
  • International Assets Investment Management's Nurix Therapeutics position peaked at $7.83K in Q2 2024.
  • 175 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.